Active Surveillance in Early Lung Cancer

Status unconfirmed · Not applicable

Conditions studied: Stage IA Non-small Cell Lung Cancer, Lung Carcinoid Tumor

In brief

Cancer patients are often given the choice of delaying or avoiding treatment as one of their options. However, there is not much information guiding lung cancer patients and their clinicians regarding this approach. Active surveillance is a way of either delaying or avoiding treatment and its possible side effects through carefully watching for changes in the tumor and considering treatment if there is progression. The purpose of this research study is to evaluate active surveillance and ways to better understand if and when to treat patients with stage IA lung cancer.

Key facts

Study ID
NCT03923777
Run by
University of Vermont Medical Center
People needed
26
Starts
2018-07-31
Expected to finish
2022-07-01
Last updated by the study team
2020-07-16

Who can join

Age: 65 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.